Published Research Summaries (click "Search" in Menu to filter)

CBD reduces seizures in treatment resistant epilepsy patients

This study examined the effects of CBD on treatment-resistant epilepsy (TRE) and was published in the journal Epilepsia in May 2023. 892 patients were given Epidiolex oral solution for a median of 694 days.

Chronic pain related to cancer reduced with cannabis medicine

Various types of pain are common in patients diagnosed with cancer. This study's goal was to examine results from cancer patients using medical cannabis. It was published in the journal BMJ Supportive & Palliative Care in May 2023.

Chronic pain patients say cannabis helps in many ways

This observational study was published in May 2023 in the journal Drug Science. They examined the effect of medical cannabis (MC) on chronic pain, quality of life, mood and sleep quality.

CBD reduces blood pressure after 2.5 weeks of use

In this randomized, placebo-controlled, crossover study, the goal was to determine the effects of oral CBD on high blood pressure (hypertension) over a 5 week period. It was published in the journal Cannabis & Cannabinoid Research in April 2023.

Tourette Syndrome patients report 75% reduction in tics with medical cannabis

The goal of this study was to examine the satisfaction, consumption habits, and THC dosing during long-term usage of medical cannabis (MC) in "resistant" Gilles de la Tourette Syndrome. It was published in May 2023 in the journal Cannabis & Cannabinoid Research.

Cannabis treatment for metastatic melanoma shows promise

This study examined the effects of cannabinoids on metastatic melanoma (skin cancer that has spread to other parts of the body). It was published in the journal Biology in May 2023.

Fibromyalgia symptoms improve with cannabinoid medicine

This study focused on changes in health-related quality of life and prevalence of adverse effects in fibromyalgia patients receiving cannabinoid medicines. It was published in the journal Brain and Behavior in May 2023.

Study: Cannabis smoking doesn't increase chances of getting COPD in tobacco smokers

Participants were followed for at least one year, although most were followed for over 4 years. It was published online ahead of print in the journal Chronic Obstructive Pulmonary Diseases in May 2023.

Myofacial pelvic pain patients report high effectiveness of cannabinoids

While the vast majority reported effectiveness for MPP pain relief, almost 97% reported an improvement in their quality of life. About 92% reported improvements in their sleep and almost 74% were able to reduce other medications after initiating cannabinoid treatment.

Patients with anxiety, chronic pain, PTSD and other conditions show improvements with cannabis medicines

This study used self-reported, observational patient data to assess cannabis' effectiveness for any condition and overall quality of life changes. It was published online in the journal Drug Science in May 2023.

CBD helps dementia patients; the 'usual medical treatment' not so much

While it was a small study, the results are very encouraging. The CBD group showed significant improvement while the group receiving the 'usual medical treatment' showed little to no improvement.

After 10 years, older HIV patients show better cognitive performance with occasional cannabis use

Over a period of up to 10 years, this study tracked levels of cannabis use and cognitive and everyday function in 297 older adults (age 50 to 84) with HIV.

Edible cannabis' effects on cancer patients - pain, cognition, quality of life

Participants were asked to take only one EDIBLE cannabis product of their choice for the entire two week period. During that time, patients took products as they needed them (ad libitum). The most common cancer type was lung, followed by colon and breast cancer.

Treatment-resistant patients say their quality of life improves with cannabinoid medicine

This original investigation examined the effects of cannabis treatment on health-related quality of life (HRQoL) in more than 3,000 patients diagnosed with several chronic, treatment-resistant conditions.

Topical CBD inhibits periodontitis

This experiment looked for the effects of CBD on common molecular markers for periodontal disease. They concluded: "CBD can be considered as a therapeutic agent for periodontitis."

Elderly mice that vape hemp and cannabis every day see benefits

This study examined the neurobiological effects of cannabis on the aging brain using a mouse model. Elderly mice were divided into three groups and exposed to cannabis flower vaporized at 210°C (410°F) in a Volcano vaporizer.

Cannabis and chronic refractory pain, including arthritis

Australian patients were prescribed cannabinoid medicines with varying ratios of THC to CBD. They generally observed that a more balanced THC:CBD ratio (similar amounts of THC and CBD) demonstrated the best results for chronic pain, including arthritis.

IBD and cannabis: a new review study

29 studies published between 2012 and 2022 were included in this review article. The studies reviewed included some randomized controlled trials (RCT) and preclinical in vivo research studies.

1 2 3 4 5 … 19

ads:

Your cart is currently empty.

Enable cookies to use the shopping cart

t: e

(-)

Item Quantity

Special instructions